Ionis Pharmaceuticals (IONS) vs PTC Therapeutics (PTCT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
PTC Therapeutics (PTCT) has outperformed Ionis Pharmaceuticals (IONS) over the past year, losing 28.1% versus a loss of 65.1%. Over five years, PTCT leads with a +48.2% price change compared with -8.5% for IONS. PTC Therapeutics is the larger company by market cap ($4.71 billion vs $4.43 billion), about 1.1 times the size.
PTC Therapeutics converts more of its revenue into profit, with a net margin of 39.4% versus -40.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IONS | PTCT |
|---|---|---|
| Share price | $26.58 | $56.42 |
| Market cap | $4.43B | $4.71B |
| 1-day change | -2.35% | -3.27% |
| YTD return | -66.40% | -25.72% |
| 1-year return | -65.07% | -28.10% |
| 5-year return | -8.50% | +48.24% |
| Forward P/E | — | 17.69 |
| EPS (TTM) | $-3.35 | $-1.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $943.71M | $1.73B |
| Revenue growth (YoY) | +33.83% | +114.51% |
| Net income (latest FY) | $-381.39M | $682.64M |
| Gross margin | 98.31% | — |
| Operating margin | -40.45% | 50.09% |
| Net margin | -40.41% | 39.44% |
| 52-week high | $86.74 | $90.87 |
| 52-week low | $26.53 | $56.18 |
| Distance from 52-week high | -69.36% | -37.91% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +155.19% | +78.08% |
| Average volume | 3.91M | 1.07M |
| Shares outstanding | 166.55M | 83.54M |
| Employees | 1,485 | 991 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PTCT has outperformed IONS by 37.0 percentage points over the past year.
- PTC Therapeutics is more profitable, keeping 39.4 cents of every revenue dollar as net income versus -40.4 cents for Ionis Pharmaceuticals.
- PTC Therapeutics grew revenue faster in its latest fiscal year (+114.51% vs +33.83%).
About Ionis Pharmaceuticals
IONS stock →Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; DAWNZERA for prophylaxis to prevent attacks of hereditary angioedema in adults; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for pediatric and adult patients with spinal muscular atrophy (SMA).
Health Care · Biotechnology: Pharmaceutical Preparations · 1,485 employees
About PTC Therapeutics
PTCT stock →PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company provides Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children.
Health Care · Biotechnology: Pharmaceutical Preparations · 991 employees
IONS vs PTCT FAQ
Which is bigger, Ionis Pharmaceuticals or PTC Therapeutics?
PTC Therapeutics (PTCT) is larger, with a market capitalization of $4.71B compared with $4.43B for Ionis Pharmaceuticals (IONS).
Which stock has performed better over the past year, IONS or PTCT?
PTCT returned -28.10% over the past 12 months, compared with -65.07% for IONS (price return, excluding dividends). Past performance does not predict future results.
Are Ionis Pharmaceuticals and PTC Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.